Три клинических случая

Список использованной литературы:

1. Roep BO. Islet autoreactive CD8 T-cells in type 1 diabetes: Licensed to kill? Diabetes 2008; 57: 1156–1157. CrossRef,PubMed,CAS,Web of Science® Times Cited: 6
2. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230–238. CrossRef,PubMed,CAS,Web of Science® Times Cited: 1890
3. Ryan EA, Shandro T, Green K et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955–962. CrossRef,PubMed,CAS,Web of Science® Times Cited: 64
4. Walter M, McDonald CG, Paty BW, Shapiro AM, Ryan EA, Senior PA. Prevalence of autoimmune diseases in islet transplant candidates with severe hypoglycaemia and glycaemic lability: Previously undiagnosed coeliac and autoimmune thyroid disease is identified by screening. Diabet Med 2007; 24: 161–165. Direct Link: AbstractFull Article (HTML)PDF(155K)ReferencesWeb of Science®
5. Koh A, Imes S, Kin T et al. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. Transplantation 2010; 89: 361–365. CrossRef,PubMed,CAS,Web of Science®
6. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177–188, quiz 189–190. CrossRef,PubMed,CAS,Web of Science®
7. Ferrando J, Grimalt R. Partial response of severe alopecia areata to cyclosporine A. Dermatology 1999; 199: 67–69. CrossRef,PubMed,CAS,Web of Science® Times Cited: 11
8.  Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK 506 in humans. Transplant Proc 1990; 22: 35–36. PubMed,CAS,Web of Science® Times Cited: 125
9. Tricot L, Lebbe C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney–pancreas transplant recipients. Transplantation 2005; 80: 1546–1549. CrossRef,PubMed,CAS,Web of Science® Times Cited: 5
10. Ushigome H, Yoshimura N, Okamoto M et al. Two cases of tacrolimus-induced alopecia following kidney transplantation. Transplant Proc 1999; 31: 2885–2886. CrossRef,PubMed,CAS,Web of Science® Times Cited: 4
11. Talbot D, Rix D, Abusin K, Mirza D, Manas D. Alopecia as a consequence of tacrolimus therapy in renal transplantation. Transplantation 1997; 64: 1631–1632. CrossRef,PubMed,CAS,Web of Science® Times Cited: 5
12. Fink J, Flasar M, Harrington J, Weir M, Bartlett S. Alopecia totalis related to tacrolimus use following kidney and pancreas transplantation [abstract presented at AST 1998]. 1998 [cited 2010 May 12 2010]; Available from: http://www.a-s-t.org/abstracts98/abs661.htm
13. Kim BJ, Min SU, Park KY et al. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat 2008; 19: 216–220. CrossRef,PubMed,CAS,Web of Science® Times Cited: 6
14. Teshima H, Kihara H, Nakagawa T, Hori Y. Effective therapy with low dose of oral cyclosporine A and prednisolone for alopecia universalis. Arerugi 1990; 39: 714–717. PubMed,CAS
15. Teshima H, Urabe A, Irie M, Nakagawa T, Nakayama J, Hori Y. Alopecia universalis treated with oral cyclosporine A and prednisolone: Immunologic studies. Int J Dermatol 1992; 31: 513–516. Direct Link: AbstractPDF(3706K)ReferencesWeb of Science® Times Cited: 16
16. Gupta AK, Ellis CN, Cooper KD et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22(2 Pt 1): 242–250. CrossRef,PubMed,CAS,Web of Science® Times Cited: 113
17. Shapiro J, Lui H, Tron V, Ho V. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 1997; 36: 114–117. CrossRef,PubMed,CAS,Web of Science® Times Cited: 24
18. Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005; 52: 138–139. CrossRef,PubMed,Web of Science® Times Cited: 17
19. Thiers BH. Topical tacrolimus: Treatment failure in a patient with alopecia areata. Arch Dermatol 2000; 136: 124. CrossRef,PubMed,CAS,Web of Science® Times Cited: 25
20. Chen CH, Wen MC, Cheng CH et al. Infectious alopecia in a dog breeder after renal transplantation. J Chin Med Assoc 2008; 71: 477–480. CrossRef,PubMed,Web of Science®
21. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 2005; 141: 759–760. CrossRef,PubMed,Web of Science® Times Cited: 17
22. Anderson C, Uwiera R, Thangavelu G. PD-1 expression is required in recent thymic emigrants to establish systemic self-tolerance. J Immunol 2010; 184(meeting abstracts 1): 143.15.
23. Truong W, Hancock WW, Plester JC et al. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol 2009; 86: 41–51. CrossRef,PubMed,CAS,Web of Science® Times Cited: 3
24. Coles A, Deans J, Compston A. Campath-1H treatment of multiple sclerosis: Lessons from the bedside for the bench. Clin Neurol Neurosurg 2004; 106: 270–274. CrossRef,PubMed,Web of Science® Times Cited: 31